Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
Journal of Chinese Physician ; (12): 1744-1747, 2016.
Article in Chinese | WPRIM | ID: wpr-506354

ABSTRACT

Vitamin D deficiency is highly prevalent in the general population including rheumatoid arthritis (RA) patients.Autocrine regulation of vitamin D modulates important immune response.Vitamin D deficiency may be involved in the pathogenesis of many autoimmune diseases including RA.Vitamin D regulates both the innate and adaptive immune responses.Vitamin D's effects on the innate immune system are mainly through the toll-like receptor and on the adaptive immune system through T cell differentiation,particularly the Helper T cell (Th) 17 response.As Thl7 cells are critical in the pathogenesis in RA,what effect will vitamin D deficiency lead to on the RA? Many data have indicated the relationship between vitamin D deficiency and RA disease activities,but not all the results are consistent.Here,we review the immune-modulatory roles of vitamin D and its effects on disease activity,osteoporosis and cardiovascular disease risk in RA.

2.
Chinese Journal of Postgraduates of Medicine ; (36): 795-798, 2016.
Article in Chinese | WPRIM | ID: wpr-497394

ABSTRACT

Objective To compare the characteristics of connective tissue disease-associated interstitial lung disease (CTD-ILD) and idiopathic pulmonary fibrosis(IPF). Methods Patients with a diagnosis of ILD from June 2014 to December 2015 were selected in this study and patients with known other causes of ILD were excluded. The clinical manifestation, autoantibody, high resolution chest computed tomography (CT) and blood gas analysis were retrospectively analyzed. Results Six hundred and twenty-eight patients were included in this study. The prevalence of CTD-ILD and IPF were 459 (73.09%) and 169(26.91%) respectively. The age in IPF group was higher than that in CTD-ILD group:(67.10 ± 13.13) years vs. (52.10 ± 14.23) years, and there was significant difference (t =-10.092, P =0.000). The rate of male in IPF group was higher than that in CTD-ILD group: 75.15%(127/169) vs. 28.32%(130/459), and there was significant difference (P=0.000). Autoantibodies were commonly seen in CTD-ILD group and only antinuclear antibody, and anti-SSA antibody and anti-Ro-52 antibody were seen in IPF group. The most common chest images were honeycombing, bullae of lung and pneumonectasis in CTD-ILD group, while the presence of consolidation and small nodular shadow were more common in IPF group. The concurrence of respiratory failure was higher in IPF group compared with that in CTD-ILD group:49.11%(83/169) vs. 13.07%(60/459), and there was significant difference (P<0.01). Conclusions Patients with CTD-ILD and IPF possess distinct characteristics. Overall assessment of clinical manifestation, autoantibody serology, high resolution chest CT and other indicator will be conducive to the differential diagnosis and treatment of ILD.

3.
Chinese Journal of Immunology ; (12): 73-76, 2015.
Article in Chinese | WPRIM | ID: wpr-458471

ABSTRACT

Objective:To observe the effect of Pidotimod and Thalidomid to enhance the immune response and protective immunity induced by the epitope Vaccines From W2b2a of Toxoplasma gondii in mice.Methods:Mice were immunized intramuscularly with Pidotimod and pcDNA3-W2b2a,thalidomide and pcDNA3-W2b2a,respectively,then the immune response and the survival time of mouse attacked by Toxoplasma gondii were observed.Results:After the immunization,the level of IFN-γin sera of mice inculated with pcDNA3-W2b2a and Pidotimod,pcDNA3-W2b2a and Freund adjuvant,pcDNA3-W2b2a and Thalidomid were significantly higher than pcDNA3-W2b2a (all P<0.05).After the immunization,IgG,CD4+/CD8+T cell ratio ,proliferation of T cell induced by pcDNA3-W2b2a and Pidotimod,pcDNA3-W2b2a and Freund adjuvant were higher than pcDNA3-W2b2a,pcDNA3-W2b2a and thalidomid ( all P<0.05).After challenged with highly virulent tachyzoites,the mean survival time in immunized groups were significantly longer than control group (all P<0.05).Conclusion:Pidotimod ,Thalidomid adjuvant can increase protective immunity of epitope Vaccines From W2b2a of Toxoplasma gondii in mice.

4.
Chinese Journal of Microbiology and Immunology ; (12): 911-914, 2012.
Article in Chinese | WPRIM | ID: wpr-429335

ABSTRACT

Objective To observe the effect of pidotimod to enhance the immune response and protective immunity induced by the epitope vaccines from new gene wx2b4a of Toxoplasma gondii in mice.Methods Mice were divided into four groups,each group was inoculated intramuscularly three times with pcDNA3-W2b4a,pcDNA3-W2b4a and pidotimod,pcDNA3,natural saline (NS),respectively.The induced immune responses were tested by ELISA detecting IgG,and flow cytometry sorting the subsets of T lymphocyte.All mice were challenged with highly virulent RH tachyzoites to observe the survival time.Results After the immunization,the level of IgG in sera of mice inoculated with wx2b4a and pidotimod,wx2b4a were significantly higher than those control group(all P<0.05).CD4+ and CD8+T cell counts in immunized groups were higher than those control group(P<0.05).After the immunization,CD4+T cell counts and CD4+/CD8+T cell proportion in wx2b4a and pidotimod groups were higher than those in wx2b4a group (all P<0.05).After challenged with highly virulent tachyzoites,the mean survival time of wx2b4a and pidotimod groups was significantly longer than control group and wx2b4a group (all P<0.05).Conclusion Pidotimod can increase protective immunity of epitope vaccines from new gene wx2b4a of Toxoplasma gondii in mice.

SELECTION OF CITATIONS
SEARCH DETAIL